谷歌浏览器插件
订阅小程序
在清言上使用

An Open-Label Long-Term Phase 3 Study of CAM2029, an Octreotide Subcutaneous Depot, in Patients with Acromegaly (ACROINNOVA 2): Interim Analysis of Patient-Reported Outcomes

Endocrine Abstracts(2024)

引用 0|浏览4
暂无评分
摘要
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要